Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Atherosclerosis of Extremities: later-stage trial registry

1 of 1 indexed Atherosclerosis of Extremities trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Atherosclerosis of Extremities: 1 US clinical trial tracked, 1 recruiting.

Atherosclerosis of Extremities is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Population Health Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition atherosclerosis-of-extremities

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Atherosclerosis of Extre (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Atherosclerosis of Extremities

Atherosclerosis of Extremities lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Atherosclerosis of Extremities on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Atherosclerosis of Extremities is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Atherosclerosis of Extremities records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Colchicine-Placebo Drug
1 trials
Colchicine 0.5 MG Oral Tablet Drug
1 trials

US sites by state

Facility locations filed on Atherosclerosis of Extremities trials. A trial with sites in several states counts in each.

Wisconsin 1 trials
Washington 1 trials
Texas 1 trials
Tennessee 1 trials
Ohio 1 trials
New Jersey 1 trials
North Carolina 1 trials
Michigan 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Atherosclerosis of Extremities page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Atherosclerosis of Extremities condition card totals 1 registered trials; most-linked intervention Colchicine-Placebo; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.